FIGURE 3.

Proportion of patients with relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL) of at most 70 years of age who received autologous stem cell transplantation (ASCT). (A) Among all patients. (B) Among patients with age under 60 years at relapse. (C) Among patients with age 60–70 years at relapse. (D) Among patients with relapse within 12 months. (E) Among patients with relapse later than 12 months. Proportions were estimated in the presence of the competing risk of death as first event. CI, confidence interval